Chronic Inflammation
Combating Chronic Inflammation at the Source
Chronic inflammation is a root cause of multiple lifestyle and degenerative conditions
Metabolic syndrome & obesity
Type 2 diabetes
Cardiovascular disease
Arthritis & joint disorders
Inflammatory Bowel Disease (IBD)
Skin disorders (eczema, psoriasis)
Neuroinflammation (brain–gut axis)
Disruption of the gut microbiome (“dysbiosis”) is strongly linked to persistent immune activation and inflammatory cytokine release.
Probiotics Reduce Inflammation
Probiotics act through multiple anti-inflammatory mechanisms:
-
Modulation of immune response
-
Strengthening gut barrier function
-
Increase in short-chain fatty acids (SCFAs) like butyrate
-
Regulation of T-regulatory cells
-
Reduction of LPS-induced systemic inflammation
Probiotic Strains for Chronic Inflammation
Lactobacillus Strains
Lactobacillus Rhamnosus GG:
Reduces gut permeability and inflammatory cytokines
Lactobacillus Plantarum:
Lowers CRP, TNF-α; supports gut barrier
Lactobacillus Casei:
Modulates immune response in arthritis and IBD
Lactobacillus Reuteri:
Anti-inflammatory effects via Treg activation
Bifidobacterium Strains
Bifidobacterium longum:
Reduces endotoxin-induced inflammation
Bifidobacterium bifidum:
Supports mucosal immunity
Bifidobacterium breve:
Shown to reduce inflammatory markers in metabolic disorders
Next-Gen Probiotics
Bacillus coagulans:
Stable, anti-inflammatory, suitable for global markets
Faecalibacterium prausnitzii:
(Next-gen) – Strong anti-inflammatory SCFA producer
Akkermansia muciniphila (Emerging):
Improves gut barrier and metabolic inflammation
Proposed Probiotic Blend
Strain | CFU per Serving |
|---|---|
Bacillus coagulans | 2 Billion |
Bifidobacterium breve | 3 Billion |
Bifidobacterium longum | 5 Billion |
Lactobacillus rhamnosus | 3 Billion |
Lactobacillus plantarum | 5 Billion |
Total CFU: 18 Billion
We offer Ready-to- Fill Probiotic Blend for Mental Well-being, Stress response, Emotional balance and gut–brain axis health with CFU suggestions, designed for B2B, Private-Label, and Global Nutraceutical markets